Growth Metrics

Nexalin Technology (NXL) Gains from Investment Securities (2022 - 2026)

Nexalin Technology has reported Gains from Investment Securities over the past 4 years, most recently at -$11331.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 108.74% year-over-year to -$11331.0; the TTM value through Dec 2025 reached $170840.0, down 65.59%, while the annual FY2025 figure was $430435.0, 85.99% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$11331.0 at Nexalin Technology, down from $185000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $2.5 million in Q3 2022 and troughed at -$11331.0 in Q4 2025.
  • A 4-year average of $489552.4 and a median of $57564.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 166339.02% in 2024 and later plummeted 108.74% in 2025.
  • Year by year, Gains from Investment Securities stood at $1340.0 in 2022, then soared by 16890.45% to $227672.0 in 2023, then tumbled by 43.07% to $129614.0 in 2024, then plummeted by 108.74% to -$11331.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for NXL at -$11331.0 in Q4 2025, $185000.0 in Q3 2025, and $32438.0 in Q2 2025.